We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

BECKMAN COULTER, INC.

Beckman Coulter develops, manufactures and markets laboratory systems, reagents, centrifugation, lab automation, elec... read more Featured Products: More products

Download Mobile App




Events

09 Apr 2024 - 12 Apr 2024
15 Apr 2024 - 17 Apr 2024
23 Apr 2024 - 26 Apr 2024

Beckman Coulter Launches Newest Version of Remisol Advance at AACC

By LabMedica International staff writers
Posted on 01 Aug 2013
Print article
Beckman Coulter, Inc. (Brea, CA, USA) has released the newest, most advanced version of Remisol Advance data management system, v1.7. This software product streamlines laboratory workflow and the management process with improved sample tracking, results archiving, and consolidation of patient test information from multiple instruments in the lab or from multiple labs in the hospital network.

Remisol Advance v1.7 unifies data management by featuring a 166% increase in sample data processing throughput and a 122% increase in sample data storage from the previous version. It helps optimize lab operations by improving results reporting turnaround times, and standardizing laboratory workflow. The new version features increased device connectivity—up to 128 instruments can now be connected to a single server. The lab may connect to Beckman Coulter analyzers as well as selected third-party instruments.

"Remisol Advance v1.7 offers scalability, security, and standardization across the lab enterprise offering benefits such as multisite connectivity, modules to support lab operations and now, third-party connectivity," said Erik Johnson, Beckman Coulter Diagnostics, director, Automation and Informatics Product Management.

Remisol Advance offers an optional Extended Quality Control (EQC) module, which enhances the laboratory quality control process even further, and features intuitive step-by-step creation of protocols.

This new version of Remisol Advance v1.7 was demonstrated at the 2013 AACC annual meeting held in Houston (TX, USA), from July 28–August 1, 2013

Related Links:

Beckman Coulter, Inc.


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Specimen Collection & Transport
POCT Fluorescent Immunoassay Analyzer
FIA Go
New
Gold Member
Systemic Autoimmune Testing Assay
BioPlex 2200 ANA Screen with MDSS

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: MOF materials efficiently enrich cfDNA and cfRNA in blood through simple operational process (Photo courtesy of Science China Press)

Blood Circulating Nucleic Acid Enrichment Technique Enables Non-Invasive Liver Cancer Diagnosis

The ability to diagnose diseases early can significantly enhance the effectiveness of clinical treatments and improve survival rates. One promising approach for non-invasive early diagnosis is the use... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The OvaCis Rapid Test discriminates benign from malignant epithelial ovarian cysts (Photo courtesy of INEX)

Intra-Operative POC Device Distinguishes Between Benign and Malignant Ovarian Cysts within 15 Minutes

Ovarian cysts represent a significant health issue for women globally, with up to 10% experiencing this condition at some point in their lives. These cysts form when fluid collects within a thin membrane... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.